Literature DB >> 2880705

Rational use of analgesics in the treatment of the rheumatic disorders.

F D Hart.   

Abstract

To the average arthritic patient, pain relief is usually his or her first priority in treatment. Thus, analgesics still have a part to play in the treatment of most arthritic conditions, even though the non-steroidal anti-inflammatory drugs (NSAIDs) have the major therapeutic role in most cases. In the treatment of acute gout, the NSAIDs are the most important, and simple analgesics are relatively unimportant, but in the treatment of rheumatoid and osteoarthritis and other arthropathies, analgesics taken as and if required to cover the more painful periods of a day do have a role, usually in conjunction with NSAIDs and other agents. In general, the simple analgesics are better tolerated than the NSAIDs and less likely to produce gastrointestinal irritation. Although many clinicians consider that simple analgesics have little part to play in the treatment of rheumatoid arthritis and other inflammatory arthropathies, the patient often takes them without the physician's knowledge, in addition to the prescribed treatment. Some recently introduced analgesics bridge the gap between the simple analgesics and the more potent potentially addictive drugs such as pethidine and morphine, which are only indicated in extremely painful crises or after traumatic episodes and surgical operations.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2880705     DOI: 10.2165/00003495-198733010-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  19 in total

1.  Comparative effectiveness of five analgesics for the pain of rheumatoid synovitis.

Authors:  J G Hardin; K A Kirk
Journal:  J Rheumatol       Date:  1979 Jul-Aug       Impact factor: 4.666

Review 2.  Butorphanol: a review of its pharmacological properties and therapeutic efficacy.

Authors:  R C Heel; R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1978-12       Impact factor: 9.546

Review 3.  Pentazocine: a review of its pharmacological properties, therapeutic efficacy and dependence liability.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1973       Impact factor: 9.546

4.  Clinical measurement of the anti-inflammatory effects of salicylates in rheumatoid arthritis.

Authors:  P L Boardman; F D Hart
Journal:  Br Med J       Date:  1967-11-04

5.  Non-steroidal analgesic and anti-inflammatory agents.

Authors:  G Nuki
Journal:  Br Med J (Clin Res Ed)       Date:  1983-07-02

6.  NSAID and osteoarthritis--help or hindrance?

Authors:  P M Brooks; S R Potter; W W Buchanan
Journal:  J Rheumatol       Date:  1982 Jan-Feb       Impact factor: 4.666

7.  Inflammatory synovitis in degenerative joint disease.

Authors:  D L Goldenberg; M S Egan; A S Cohen
Journal:  J Rheumatol       Date:  1982 Mar-Apr       Impact factor: 4.666

8.  Pain relief in the rheumatic and other disorders.

Authors:  F D Hart
Journal:  Int Rehabil Med       Date:  1985

Review 9.  Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy.

Authors:  J K Errick; R C Heel
Journal:  Drugs       Date:  1983-09       Impact factor: 9.546

Review 10.  Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B Holmes; A Ward
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

View more
  1 in total

1.  Aceclofenac in rheumatoid arthritis: a useful and novel anti-inflammatory.

Authors:  J A Hunter; M J Parnham; X G Balaguer
Journal:  Clin Rheumatol       Date:  1996-07       Impact factor: 2.980

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.